VIP
AGN

Vantage Investment Partners’s Allergan plc AGN Stock Holding History

Vantage Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-64,500
Closed -$12.3M – 102
2018
Q3 		$12.3M Buy
64,500
+2,400
+4% +$441K 0.77% 20
2018
Q2 		$10.4M Buy
62,100
+16,800
+37% +$2.7M 0.75% 22
2018
Q1 		$7.62M Buy
+45,300
New +$7.6M 0.63% 58

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vantage Investment Partners's AGN Position: Q4 2018 in Review

Vantage Investment Partners sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 64,500 shares — an estimated $12.3M sold.

Vantage Investment Partners first reported a position in AGN in Q1 2018 and held it in 3 quarters. The position peaked at $12.3M in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Vantage Investment Partners reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Vantage Investment Partners sold 64,500 Allergan plc shares in Q4 2018, an estimated $12.3M.
  • Vantage Investment Partners first reported a position in Allergan plc in Q1 2018 and held it in 3 quarters.
  • Vantage Investment Partners's Allergan plc position peaked at $12.3M in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Vantage Investment Partners's 13F filing for Q4 2018, filed 6 Feb 2019.